Establishing Proximal and Distal Regional Identities in Murine and Human Tissue-Engineered Lung and Trachea
Overview
Biotechnology
Authors
Affiliations
The cellular and molecular mechanisms that underpin regeneration of the human lung are unknown, and the study of lung repair has been impeded by the necessity for reductionist models that may exclude key components. We hypothesized that multicellular epithelial and mesenchymal cell clusters or lung organoid units (LuOU) could be transplanted to recapitulate proximal and distal cellular structures of the native lung and airways. Transplantation of LuOU resulted in the growth of tissue-engineered lung (TELu) that contained the necessary cell types consistent with native adult lung tissue and demonstrated proliferative cells at 2 and 4 weeks. This technique recapitulated important elements of both mouse and human lungs featuring key components of both the proximal and distal lung regions. When LuOU were generated from whole lung, TELu contained key epithelial and mesenchymal cell types, and the origin of the cells was traced from both Actin and SPC donors to indicate that the cells in TELu were derived from the transplanted LuOU. Alveolar epithelial type 2 cells (AEC2s), club cells, ciliated cells marked by beta-tubulin IV, alveolar epithelial type I cells, Sox-2-positive proximal airway progenitors, p63-positive basal cells, and CGRP-positive pulmonary neuroendocrine cells were identified in the TELu. The mesenchymal components of peribronchial smooth muscle and nerve were identified with a CD31-positive donor endothelial cell contribution to TELu vasculature. TELu successfully grew from postnatal tissues from whole murine and human lung, distal murine lung, as well as murine and human trachea. These data support a model of postnatal lung regeneration containing the diverse cell types present in the entirety of the respiratory tract.
Lung Organoids: Systematic Review of Recent Advancements and its Future Perspectives.
Thangam T, Parthasarathy K, Supraja K, Haribalaji V, Sounderrajan V, Rao S Tissue Eng Regen Med. 2024; 21(5):653-671.
PMID: 38466362 PMC: 11187038. DOI: 10.1007/s13770-024-00628-2.
Human Lung Organoids-A Novel Experimental and Precision Medicine Approach.
Kuhl L, Graichen P, von Daacke N, Mende A, Wygrecka M, Potaczek D Cells. 2023; 12(16).
PMID: 37626876 PMC: 10453737. DOI: 10.3390/cells12162067.
Esophageal organoids: applications and future prospects.
Liu H, Wang X J Mol Med (Berl). 2023; 101(8):931-945.
PMID: 37380866 DOI: 10.1007/s00109-023-02340-5.
Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.
Sachdeva U, Shimonosono M, Flashner S, Cruz-Acuna R, Gabre J, Nakagawa H Cancer Lett. 2021; 509:39-52.
PMID: 33838281 PMC: 8493518. DOI: 10.1016/j.canlet.2021.03.031.
Lung organoids, useful tools for investigating epithelial repair after lung injury.
Kong J, Wen S, Cao W, Yue P, Xu X, Zhang Y Stem Cell Res Ther. 2021; 12(1):95.
PMID: 33516265 PMC: 7846910. DOI: 10.1186/s13287-021-02172-5.